Exploring the therapeutic role of creatine supplementation
The DOI matches its Crossref record; 139 of the 140 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Creatine (Cr) plays a central role in energy provision through a reaction catalyzed by phosphorylcreatine kinase. Furthermore, this amine enhances both gene expression and satellite cell activation involved in hypertrophic response. Recent findings have indicated that Cr supplementation has a therapeutic role in several diseases characterized by atrophic conditions, weakness, and metabolic disturbances (i.e., in the muscle, bone, lung, and brain). Accordingly, there has been an evidence indicating that Cr supplementation is capable of attenuating the degenerative state in some muscle disorders (i.e., Duchenne and inflammatory myopathies), central nervous diseases (i.e., Parkinson's, Huntington's, and Alzheimer's), and bone and metabolic disturbances (i.e., osteoporosis and type II diabetes). In light of this, Cr supplementation could be used as a therapeutic tool for the elderly. The aim of this review is to summarize the main studies conducted in this field and to highlight the scientific and clinical perspectives of this promising therapeutic supplement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There has been an increasing number of studies showing that creatine supplementation plays a therapeutic role in a variety of clinical conditions (see Gualano et al. [106] for a comprehensive review on this topic).”
From Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? (2021) · cites this paper as [106]
In the citing paper
“Thus, there is evidence to suggest that creatine supplementation enhances glucose uptake and insulin sensitivity and, therefore, can help individuals manage glucose and HbA1c levels, particularly when initiating an exercise program [10,11,186].”
From Creatine in health and disease (2021) · cites this paper as [186]
Citations
Cites
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950 · cited 2×
“In addition, attenuation has been observed in the release of intracellular calcium as a result of Cr supplementation (Wyss and Kaddurah-Daouk 2000).”
BackgroundWalker, F. O. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60111-1 · Cited by 2,603
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
Evidence for prescribing exercise as therapy in chronic disease
Pedersen, B. K., & Saltin, B. (2006) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/j.1600-0838.2006.00520.x · Cited by 1,384
Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation
Harris, R. C., Söderlund, K., & Hultman, E. (1992) · Clinical Science · doi:10.1042/cs0830367 · Cited by 1,168
Marquis, K., Debigaré, R., Lacasse, Y., LeBlanc, P., Jobin, J., Carrier, G., & Maltais, F. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2107031 · Cited by 844 · cited 2×
“Atrophy is a strong and independent predictor of mortality in patients with chronic obstructive pulmonary disease (COPD) (Marquis et al. 2002). Furthermore, COPD patients present decreased muscle PCr content (Green et al. 2008). Thus, the use of Cr supplementation in this disease could be justified. Fuld et al. (2005)…”
BackgroundDupuis, L., Oudart, H., René, F., de Aguilar, J.-L. G., & Loeffler, J.-P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402026101 · Cited by 529
Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease
Ferrante, R. J., Andreassen, O. A., Jenkins, B. G., Dedeoglu, A., Kuemmerle, S., Kubilus, J. K., Kaddurah-Daouk, R., Hersch, S. M., & Beal, M. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04389.2000 · Cited by 522
AAEM minimonograph #26: The electrodiagnosis of carpal tunnel syndrome
Stevens, J. C. (1997) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199712)20:12 · Cited by 518
Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats
Alam, M., & Schmidt, W. J. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00180-8 · Cited by 473 · cited 1×
“Evidence indicates that a defect in electron transport chain might be involved in the Parkinson’s physiopathology (Alam and Schmidt 2002; Schapira et al. 1990), which implies that therapeutic strategies focused on improvement in mitochondrial function may be promising in this pathology.”
BackgroundThe NINDS NET-PD Investigators (2006) · Neurology · doi:10.1212/01.wnl.0000201252.57661.e1 · Cited by 453
Creatine deficiency in the brain: A new, treatable inborn error of metabolism
Stöckler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., Hänicke, W., & Frahm, J. (1994) · Pediatric Research · doi:10.1203/00006450-199409000-00023 · Cited by 417
Physiological and Health Effects of Oral Creatine Supplementation
(2000) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200003000-00024 · Cited by 413 · cited 2×
“Interestingly, it has been demonstrated that Cr-induced lean mass increase is not exclusively explained by water retention, as believed previously (Francaux and Poortmans 1999; Terjung et al. 2000).”
BackgroundX-Linked Creatine-Transporter Gene (SLC6A8) Defect: A New Creatine-Deficiency Syndrome
Salomons, G. S., van Dooren, S. J. M., Verhoeven, N. M., Cecil, K. M., Ball, W. S., Degrauw, T. J., & Jakobs, C. (2001) · The American Journal of Human Genetics · doi:10.1086/320595 · Cited by 396
Creatine kinase in non-muscle tissues and cells
Wallimann, T., & Hemmer, W. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf01267955 · Cited by 374 · cited 2×
“Instead, this study corroborates the role of Cr bioenergetics on bone, possibly elevating PCr/Cr ratio and preserving the mitochondrial function and ultrastructure (Wallimann and Hemmer 1994).”
BackgroundFunctions and effects of creatine in the central nervous system
Andres, R. H., Ducray, A. D., Schlattner, U., Wallimann, T., & Widmer, H. R. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.02.035 · Cited by 368
ATP flux through creatine kinase in the normal, stressed, and failing human heart
Weiss, R. G., Gerstenblith, G., & Bottomley, P. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408962102 · Cited by 350 · cited 1×
“1988) and cardiac ATP flux through PCK (Weiss et al. 2005).”
BackgroundOlsen, S., Aagaard, P., Kadi, F., Tufekovic, G., Verney, J., Olesen, J. L., Suetta, C., & Kjær, M. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.107359 · Cited by 319 · cited 1×
“2008), as well as satellite cell activation (Olsen et al. 2006).”
BackgroundCreatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′dG
Hersch, S. M., Gevorkian, S., Marder, K., Moskowitz, C., Feigin, A., Cox, M., Como, P., Zimmerman, C., Lin, M., Zhang, L., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000194318.74946.b6 · Cited by 313
A clinical trial of creatine in ALS
Shefner, J. M., Cudkowicz, M. E., Schoenfeld, D., Conrad, T., Taft, J., Chilton, M., Urbinelli, L., Qureshi, M., Zhang, H., Pestronk, A., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000142992.81995.f0 · Cited by 293
Sabra, A., Bellanti, J. A., & Colón, A. R. (1998) · The Lancet · doi:10.1016/s0140-6736(05)77837-5 · Cited by 287
A randomized sequential trial of creatine in amyotrophic lateral sclerosis
Jan Groeneveld, G., Veldink, J. H., van der Tweel, I., Kalmijn, S., Beijer, C., de Visser, M., Wokke, J. H. J., Franssen, H., & Berg, L. H. V. D. (2003) · Annals of Neurology · doi:10.1002/ana.10554 · Cited by 283
Brose, A., Parise, G., & Tarnopolsky, M. A. (2003) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/58.1.b11 · Cited by 274
Nissen, S. L., & Sharp, R. L. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00755.2002 · Cited by 258
(2013) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-59565-2.00053-8 · Cited by 251
Stöckler, S., Hanefeld, F., & Frahm, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04116-5 · Cited by 240 · cited 1×
“In contrast, efforts using Cr supplementation and aiming to attenuate the neurological disturbances induced by deficiency in Cr transporter (CreaT) have been fruitless (Stockler et al. 1996).”
BackgroundParise, G., Mihic, S., MacLennan, D., Yarasheski, K. E., & Tarnopolsky, M. A. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.3.1041 · Cited by 236 · cited 1×
“increase in protein skeletal muscle induced by this supplement under resting or exercise conditions (Louis et al. 2003b; Parise et al. 2001), recent studies have indicated that Cr supplementation can markedly reduce muscle catabolism (Menezes et al.”
BackgroundItem, C. B., Stöckler-Ipsiroglu, S., Stromberger, C., Mühl, A., Alessandrì, M. G., Bianchi, M. C., Tosetti, M., Fornai, F., & Cioni, G. (2001) · The American Journal of Human Genetics · doi:10.1086/323765 · Cited by 233
Brewer, G. J., & Wallimann, T. W. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741968.x · Cited by 230
Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy
Tarnopolsky, M. A., Mahoney, D. J., Vajsar, J., Rodriguez, C., Doherty, T. J., Roy, B. D., & Biggar, D. (2004) · Neurology · doi:10.1212/01.wnl.0000125178.18862.9d · Cited by 216
Long-term oral creatine supplementation does not impair renal function in healthy athletes
POORTMANS, J. R., & FRANCAUX, M. (1999) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199908000-00005 · Cited by 215
Self-citationRenal dysfunction accompanying oral creatine supplements
Pritchard, N., & Kalra, P. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79319-3 · Cited by 213 · cited 1×
“major controversial point refers to renal function, since a few case reports have attributed renal dysfunction to Cr supplementation (Kuehl et al. 1998; Pritchard and Kalra 1998; Thorsteinsdottir et al. 2006).”
BackgroundCreatine supplementation in Parkinson disease: A placebo-controlled randomized pilot trial
Bender, A., Koch, W., Elstner, M., Schombacher, Y., Bender, J., Moeschl, M., Gekeler, F., Müller-Myhsok, B., Gasser, T., Tatsch, K., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000238518.34389.12 · Cited by 204
Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation
Watanabe, A., Kato, N., & Kato, T. (2002) · Neuroscience Research · doi:10.1016/s0168-0102(02)00007-x · Cited by 196 · cited 1×
“The results have indicated that this supplement is able to improve brain function in young subjects (Watanabe et al. 2002) as well as in elderly people (McMorris et al.”
BackgroundGORDON, A. (1995) · Cardiovascular Research · doi:10.1016/0008-6363(95)00062-3 · Cited by 195
Guerrero-Ontiveros, M. L., & Wallimann, T. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006895414925 · Cited by 192
Schulze, A. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1022443503883 · Cited by 189 · cited 3×
“, months or even years) in order to at least partially replenish cerebral Cr content (Battini et al. 2006; Schulze 2003).”
BackgroundInfluentialKreider, R. B., Melton, C., Rasmussen, C. J., Greenwood, M., Lancaster, S., Cantler, E. C., Milnor, P., & Almada, A. L. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1022469320296 · Cited by 181 · cited 1×
“2005; Poortmans and Francaux 2008) and others (Kreider et al. 2003; Robinson et al. 2000) have repeatedly demonstrated that Cr supplementation does not induce renal disease in healthy individuals.”
BackgroundAdverse Effects of Creatine Supplementation: Fact or Fiction?
Poortmans, J. R., & Francaux, M. (2000) · Sports Medicine · doi:10.2165/00007256-200030030-00002 · Cited by 176
Self-citationA randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies
Tarnopolsky, M. A., Roy, B. D., & MacDonald, J. R. (1997) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199712)20:12<1502::aid-mus4>3.0.co;2-c · Cited by 173
Effect of short-term creatine supplementation on renal responses in men
Poortmans, J. R., Auquier, H., Renaut, V., Durussel, A., Saugy, M., & Brisson, G. R. (1997) · European Journal of Applied Physiology · doi:10.1007/s004210050291 · Cited by 170
Self-citationCreatine for treating muscle disorders
Kley, R. A., Tarnopolsky, M. A., & Vorgerd, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004760.pub4 · Cited by 169
Guerrero-Ontiveros, M. L., & Wallimann, T. (1998) · Bioenergetics of the Cell: Quantitative Aspects · doi:10.1007/978-1-4615-5653-4_30 · Cited by 168
Low-Dose Creatine Combined with Protein during Resistance Training in Older Men
CANDOW, D. G., LITTLE, J. P., CHILIBECK, P. D., ABEYSEKARA, S., ZELLO, G. A., KAZACHKOV, M., CORNISH, S. M., & YU, P. H. (2008) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318176b310 · Cited by 168
McMorris, T., Harris, R. C., Swain, J., Corbett, J., Collard, K., Dyson, R. J., Dye, L., Hodgson, C., & Draper, N. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0269-z · Cited by 168 · cited 3×
“ations (McMorris et al. 2007a; McMorris et al. 2006).”
BackgroundInfluentialCreatine monohydrate increases strength in patients with neuromuscular disease
Tarnopolsky, M., & Martin, J. (1999) · Neurology · doi:10.1212/wnl.52.4.854 · Cited by 165 · cited 1×
“Accordingly, the same group reported strength and weight gain in patients with muscle dystrophies, cytopathies, inflammatory myopathies, and peripheral neuropathy disorders (n = 21) supplemented with Cr for 11 days (Tarnopolsky and Martin 1999).”
BackgroundCreatine supplementation in Huntington’s disease: A placebo-controlled pilot trial
Verbessem, P., Lemiere, J., Eijnde, B. O., Swinnen, S., Vanhees, L., Van Leemputte, M., Hespel, P., & Dom, R. (2003) · Neurology · doi:10.1212/01.wnl.0000090629.40891.4b · Cited by 161
Browne, S. E., Yang, L., DiMauro, J.-P., Fuller, S. W., Licata, S. C., & Beal, M. F. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.001 · Cited by 160
Safdar, A., Yardley, N. J., Snow, R., Melov, S., & Tarnopolsky, M. A. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00157.2007 · Cited by 149 · cited 1×
“Instead, there is a strong evidence suggesting that Cr supplementation could promote overexpression of genes and proteins related to hypertrophy (Deldicque et al. 2008; Safdar et al. 2008), as well as satellite cell activation (Olsen et al.”
BackgroundCreatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease
Fuld, J. P. (2005) · Thorax · doi:10.1136/thx.2004.030452 · Cited by 145
Deldicque, L., Atherton, P., Patel, R., Theisen, D., Nielens, H., Rennie, M. J., & Francaux, M. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00873.2007 · Cited by 141
Creatine supplementation lowers brain glutamate levels in Huntington?s disease
Bender, A., Auer, D. P., Merl, T., Reilmann, R., Saemann, P., Yassouridis, A., Bender, J., Weindl, A., Dose, M., Gasser, T., et al. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0595-4 · Cited by 141
Creatine monohydrate in muscular dystrophies: a double-blind, placebo-controlled clinical study
Walter, M. C., Lochmüller, H., Reilich, P., Klopstock, T., Huber, R., Hartard, M., Hennig, M., Pongratz, D., & Müller–Felber, W. (2000) · Neurology · doi:10.1212/wnl.54.9.1848 · Cited by 137
Creatine Supplementation and Cognitive Performance in Elderly Individuals
McMorris, T., Mielcarz, G., Harris, R. C., Swain, J. P., & Howard, A. (2007) · Aging, Neuropsychology, and Cognition · doi:10.1080/13825580600788100 · Cited by 134
Vorgerd, M., Grehl, T., Jäger, M., Müller, K., Freitag, G., Patzold, T., Bruns, N., Fabian, K., Tegenthoff, M., Mortier, W., et al. (2000) · Archives of Neurology · doi:10.1001/archneur.57.7.956 · Cited by 131
Exocytotic release of creatine in rat brain
Almeida, L. S., Salomons, G. S., Hogenboom, F., Jakobs, C., & Schoffelmeer, A. N. M. (2006) · Synapse · doi:10.1002/syn.20280 · Cited by 130
Beneficial effects of creatine supplementation in dystrophic patients
Louis, M., Lebacq, J., Poortmans, J. R., Belpaire‐Dethiou, M., Devogelaer, J., Van Hecke, P., Goubel, F., & Francaux, M. (2003) · Muscle & Nerve · doi:10.1002/mus.10355 · Cited by 130
Self-citationHass, C. J., Collins, M. A., & Juncos, J. L. (2007) · Neurorehabilitation and Neural Repair · doi:10.1177/1545968306293449 · Cited by 129
Hyperammonemia-induced toxicity for the developing central nervous system
Cagnon, L., & Braissant, O. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.06.026 · Cited by 128
De Deyn, P. P., & Macdonald, R. L. (1990) · Annals of Neurology · doi:10.1002/ana.410280505 · Cited by 126
Stout, J. R., Graves, B. S., Cramer, J. T., Goldstein, E. R., Costa, P. B., Smith‐Ryan, A. E., & Walter, A. A. (2007) · PubMed · Cited by 122
MANCINI, D. M., Ferraro, N., Tuchler, M., Chance, B., & Wilson, J. R. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90266-4 · Cited by 121 · cited 1×
“It has been demonstrated that patients with heart failure have both diminished muscle Cr (Mancini et al. 1988) and cardiac ATP flux through PCK (Weiss et al.”
BackgroundSakellaris, G., Kotsiou, M., Tamiolaki, M., Kalostos, G., Tsapaki, E., Spanaki, M., Spilioti, M., Charissis, G., & Evangeliou, A. (2006) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/01.ta.0000230269.46108.d5 · Cited by 116
Resistance Exercise Training in Patients with Heart Failure
Volaklis, K. A., & Tokmakidis, S. P. (2005) · Sports Medicine · doi:10.2165/00007256-200535120-00006 · Cited by 116 · cited 1×
“Additionally, it is tempting to speculate that Cr supplementation can beneficially affect the skeletal muscle disorders previously reported in this population (Volaklis and Tokmakidis 2005).”
BackgroundBraissant, O., & Henry, H. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0826-9 · Cited by 116
Robinson, T. M., Sewell, D. A., Casey, A., Steenge, G., & Greenhaff, P. L. (2000) · British Journal of Sports Medicine · doi:10.1136/bjsm.34.4.284 · Cited by 115 · cited 1×
“2005; Poortmans and Francaux 2008) and others (Kreider et al. 2003; Robinson et al. 2000) have repeatedly demonstrated that Cr supplementation does not induce renal disease in healthy individuals.”
BackgroundCreatine supplementation, sleep deprivation, cortisol, melatonin and behavior
McMorris, T., Harris, R. C., Howard, A. N., Langridge, G., Hall, B., Corbett, J., Dicks, M., & Hodgson, C. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.08.024 · Cited by 115
Passaquin, A.-C., Renard, M., Kay, L., Challet, C., Mokhtarian, A., Wallimann, T., & Ruegg, U. T. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(01)00273-5 · Cited by 112
Chung, Y., Alexanderson, H., Pipitone, N., Morrison, C., Dastmalchi, M., Ståhl‐Hallengren, C., Richards, S., Thomas, E. L., Hamilton, G., Bell, J. D., et al. (2007) · Arthritis Care & Research · doi:10.1002/art.22687 · Cited by 112
Mazzini, L., Balzarini, C., Colombo, R., Mora, G., Pastore, I., Ambrogio, R. D., & Caligari, M. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00611-6 · Cited by 111
CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy
Escolar, D. M., Buyse, G., Henricson, E., Leshner, R., Florence, J., Mayhew, J., Tesi‐Rocha, C., Gorni, K., Pasquali, L., Patel, K. M., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20523 · Cited by 107
Ammonium-Induced Impairment of Axonal Growth Is Prevented through Glial Creatine
Braissant, O., Henry, H., Villard, A.-M., Zurich, M.-G., Loup, M., Eilers, B., Parlascino, G., Matter, E., Boulat, O., Honegger, P., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09810.2002 · Cited by 106
Andrews, R. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0767 · Cited by 103
Battini, R., Alessandrì, M. G., Leuzzi, V., Moro, F., Tosetti, M., Bianchi, M. C., & Cioni, G. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.01.043 · Cited by 101
Bioenergetics in Huntington's Disease
GRÜNEWALD, T., & BEAL, M. F. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07827.x · Cited by 101
Louis, M., Poortmans, J. R., Francaux, M., Berré, J., Boisseau, N., Brassine, E., Cuthbertson, D. J. R., Smith, K., Babraj, J. A., Waddell, T., et al. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00195.2003 · Cited by 100
Self-citation‘Hot spots’ of creatine kinase localization in brain: cerebellum, hippocampus and choroid plexus
Kaldis, P., Hemmer, W., Zanolla, E., Holtzman, D., & Wallimann, T. (2009) · Developmental Neuroscience · doi:10.1159/000111452 · Cited by 99 · cited 1×
“There is enough evidence showing the presence of PCK in pyramidal cells, which are involved in memory and learning process (Kaldis et al. 1996).”
BackgroundAdcock, K. H., Nedelcu, J., Loenneker, T., Martin, E., Wallimann, T., & Wagner, B. P. (2002) · Developmental Neuroscience · doi:10.1159/000069043 · Cited by 97 · cited 1×
“Interestingly, a body of literature indicates that energetic disturbances induced by ischemia, cerebral vascular stroke, spinal cord injury, and cerebral trauma might be attenuated by Cr treatment (Adcock et al. 2002; Lensman et al. 2006; Ozkan et al. 2005; Scheff and Dhillon 2004).”
BackgroundAksenov, M. Y., Aksenova, M. V., Payne, R. M., Smith, C. D., Markesbery, W. R., & Carney, J. M. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6550 · Cited by 97 · cited 1×
“Cerebral PCK expression seems to be reduced in patients with this disease (Aksenov et al. 1997).”
BackgroundEffects of training and creatine supplement on muscle strength and body mass
Francaux, M., & POORTMANS, J. R. (1999) · European Journal of Applied Physiology and Occupational Physiology · doi:10.1007/s004210050575 · Cited by 96
Self-citationRawson, E. S., Clarkson, P. M., Price, T. B., & Miles, M. P. (2002) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2002.00924.x · Cited by 94 · cited 1×
“Following short-term Cr supplementation, senior subjects exhibit smaller increases in PCr than young subjects (Rawson et al. 2002).”
BackgroundHigh-dose creatine therapy for Huntington disease: A 2-year clinical and MRS study
Tabrizi, S. J., Blamire, A. M., Manners, D. N., Rajagopalan, B., Styles, P., Schapira, A. H. V., & Warner, T. T. (2005) · Neurology · doi:10.1212/01.wnl.0000160388.96242.77 · Cited by 93
Effect of Oral Creatine Supplementation on Urinary Methylamine, Formaldehyde, and Formate
POORTMANS, J. R., KUMPS, A., DUEZ, P., FOFONKA, A., CARPENTIER, A., & FRANCAUX, M. (2005) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000176398.64189.e6 · Cited by 91 · cited 1×
“However, our groups (Gualano et al. 2008c; Poortmans 1998; Poortmans and Francaux 2008 Poortmans et al. 1997; Poortmans and Francaux 1999, 2000; Poortmans et al. 2005; Poortmans and Francaux 2008) and others (Kreider et al.”
BackgroundSelf-citationDeacon, S. J., Vincent, E. E., Greenhaff, P. L., Fox, J., Steiner, M. C., Singh, S. J., & Morgan, M. D. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200710-1508oc · Cited by 90
Earnest, C. P., Almada, A. L., & Mitchell, T. L. (1996) · Clinical Science · doi:10.1042/cs0910113 · Cited by 88
Gualano, B., Ugrinowitsch, C., Novaes, R. B., Artioli, G. G., Shimizu, M. H., Seguro, A. C., Harris, R. C., & Lancha, A. H. (2008) · European Journal of Applied Physiology · doi:10.1007/s00421-007-0669-3 · Cited by 88
Self-citationVorgerd, M., Zange, J., Kley, R., Grehl, T., Hüsing, A., Jäger, M., Müller, K., Schröder, R., Mortier, W., Fabian, K., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.1.97 · Cited by 88
Creatine therapy for Huntington’s disease: Clinical and MRS findings in a 1-year pilot study
Tabrizi, S. J., Blamire, A. M., Manners, D. N., Rajagopalan, B., Styles, P., Schapira, A. H. V., & Warner, T. T. (2003) · Neurology · doi:10.1212/01.wnl.0000070186.97463.a7 · Cited by 87
Creatine improves health and survival of mice
Bender, A., Beckers, J., Schneider, I., Hölter, S. M., Haack, T., Ruthsatz, T., Vogt-Weisenhorn, D. M., Becker, L., Genius, J., Rujescu, D., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.001 · Cited by 81
Thorsteinsdottir, B., Grande, J. P., & Garovic, V. D. (2006) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2006.04.025 · Cited by 80 · cited 1×
“major controversial point refers to renal function, since a few case reports have attributed renal dysfunction to Cr supplementation (Kuehl et al. 1998; Pritchard and Kalra 1998; Thorsteinsdottir et al. 2006).”
BackgroundGualano, B., Novaes, R. B., Artioli, G. G., Freire, T. O., Df, C., Scagliusi, F. B., Rogeri, P. S., Roschel, H., Ugrinowitsch, C., & Lancha, A. H. (2007) · Amino Acids · doi:10.1007/s00726-007-0508-1 · Cited by 80
Self-citationThe therapeutic role of creatine in Huntington's disease
Ryu, H., Rosas, H. D., Hersch, S. M., & Ferrante, R. J. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.008 · Cited by 79 · cited 2×
“2005), as well as normalizing cerebral Cr content (Ryu et al. 2005).”
BackgroundMethodEffect of creatine supplementation on creatine and glycogen content in rat skeletal muscle
Op ‘t Eijnde, B., Richter, E. A., Henquin, J. ‐., Kiens, B., & Hespel, P. (2001) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2001.00786.x · Cited by 79 · cited 1×
“Interestingly, Op‘t Eijnde et al. (2001) showed that Cr intake increases GLUT-4 protein content in line with glycogen accumulation during muscle disuse by Creatine supplementation and therapeutic effects”
BackgroundReduced creatine kinase activity in transgenic amyotrophic lateral sclerosis mice
Wendt, S., Dedeoglu, A., Speer, O., Wallimann, T., Beal, M. F., & Andreassen, O. A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00784-0 · Cited by 75 · cited 1×
“2006) and PCK activity were observed (Wendt et al. 2002).”
Creatine monohydrate and resistance training increase bone mineral content and density in older men.
(2005) · PubMed · Cited by 75
Creatine-Enhanced Diet Alters Levels of Lactate and Free Fatty Acids After Experimental Brain Injury
Scheff, S. W., & DHILLON, H. S. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000013753.22615.59 · Cited by 74 · cited 1×
“Interestingly, a body of literature indicates that energetic disturbances induced by ischemia, cerebral vascular stroke, spinal cord injury, and cerebral trauma might be attenuated by Cr treatment (Adcock et al. 2002; Lensman et al. 2006; Ozkan et al. 2005; Scheff and Dhillon 2004).”
BackgroundA placebo-controlled crossover trial of creatine in mitochondrial diseases
Klopstock, T., Querner, V., Schmidt, F., Gekeler, F., Walter, M., Hartard, M., Dipl-Stat, M. H., Gasser, T., Pongratz, D., Straube, A., et al. (2000) · Neurology · doi:10.1212/wnl.55.11.1748 · Cited by 72
Creatine-dextrose and protein-dextrose induce similar strength gains during training
TARNOPOLSKY, M. A., PARISE, G., YARDLEY, N. J., BALLANTYNE, C. S., OLATUNJI, S., & PHILLIPS, S. M. (2001) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200112000-00011 · Cited by 71 · cited 1×
“supplemented with an isoenergetic and isonitrogenous diet (Tarnopolsky et al. 2001).”
BackgroundRabchevsky, A. G., Sullivan, P. G., Fugaccia, I., & Scheff, S. W. (2003) · Journal of Neurotrauma · doi:10.1089/089771503322144572 · Cited by 70 · cited 1×
“Similar findings were obtained in animal models with spinal cord injury, although the benefits observed were less evident (Hausmann et al. 2002; Rabchevsky et al. 2003).”
ResultBrain creatine functions to attenuate acute stress responses through GABAnergic system in chicks
Koga, Y., Takahashi, H., Oikawa, D., Tachibana, T., Denbow, D. M., & Furuse, M. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.004 · Cited by 70 · cited 1×
“compounds, including Cr, may affect GABAergic neurotransmission as (partial) agonists for GABAA receptors, suggesting a role of this compound as a central neuromodulator (De Deyn and Macdonald 1990; De Deyn and Wirshing 2001; Koga et al. 2005).”
BackgroundThe creatine-phosphocreatine system: there's more than one song in its repertoire
Greenhaff, P. L. (2001) · The Journal of Physiology · doi:10.1113/jphysiol.2001.013478 · Cited by 70
The creatine-phosphocreatine system: there's more than one song in its repertoire
Greenhaff, P. L. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.00657.x · Cited by 69
Clinical Use of Creatine in Neuromuscular and Neurometabolic Disorders
Tarnopolsky, M. A. (2007) · Subcellular Biochemistry · doi:10.1007/978-1-4020-6486-9_10 · Cited by 67 · cited 3×
“First, as highlighted by Tarnopolsky (2007), ‘‘certain disorders such as amyotrophic lateral sclerosis (ALS) or polymyositis show either a rapid decline or improvement in function, respectively, and a parallel design is more appropriate.”
BackgroundInfluentialTarnopolsky, M. A., Bourgeois, J. M., Snow, R., Keys, S., Roy, B. D., Kwiecien, J. M., & Turnbull, J. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00270.2003 · Cited by 67
Institute of Cell Biology, E. H., Gerber, I., ap Gwynn, I., Alini, M., & Wallimann, T. (2005) · European Cells and Materials · doi:10.22203/ecm.v010a02 · Cited by 66
Kornblum, C., Schröder, R., Müller, K., Vorgerd, M., Eggers, J., Bogdanow, M., Papassotiropoulos, A., Fabian, K., Klockgether, T., & Zange, J. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00970.x · Cited by 65
Lensman, M. V., Korzhevsky, D. E., Mourovets, V. O., Kostkin, V. B., Izvarina, N. L., Perasso, L., Gandolfo, C., Otellin, V. A., Polenov, S. A., & Balestrino, M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.06.103 · Cited by 65 · cited 1×
“Interestingly, a body of literature indicates that energetic disturbances induced by ischemia, cerebral vascular stroke, spinal cord injury, and cerebral trauma might be attenuated by Cr treatment (Adcock et al. 2002; Lensman et al. 2006; Ozkan et al. 2005; Scheff and Dhillon 2004).”
BackgroundProtective effects of oral creatine supplementation on spinal cord injury in rats
Hausmann, O., Fouad, K., Wallimann, T., & Schwab, M. (2002) · Spinal Cord · doi:10.1038/sj.sc.3101330 · Cited by 61
In‘t Zandt, H. J. A., Renema, W. K. J., Streijger, F., Jost, C., Klomp, D. W. J., Oerlemans, F., Van der Zee, C. E. E. M., Wieringa, B., & Heerschap, A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02599.x · Cited by 60
Does oral creatine supplementation improve strength? A meta-analysis.
Dempsey, R. L., Mazzone, M. F., & Meurer, L. N. (2002) · PubMed · Cited by 56
Tarnopolsky, M., Mahoney, D., Thompson, T., Naylor, H., & Doherty, T. J. (2004) · Muscle & Nerve · doi:10.1002/mus.10527 · Cited by 54
Creatine supplementation improves muscle strength in patients with congestive heart failure.
Kuethe, F., Krack, A., Richartz, B. M., & Figulla, H. R. (2006) · PubMed · Cited by 53
Creatine monohydrate in myotonic dystrophy
Walter, M. C., Reilich, P., Lochm�ller, H., Kohnen, R., Schlotter, B., Hautmann, H., Dunkl, E., Pongratz, D., & M�ller-Felber, W. (2002) · Journal of Neurology · doi:10.1007/s00415-002-0923-x · Cited by 53
Menezes, L. G., Sobreira, C., Neder, L., Rodrigues-Júnior, A. L., & Baddini Martinez, J. A. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01188.2005 · Cited by 50
Moxley, R. T., Ricker, K., Chad, D. A., Lacomis, D., Skare, J. C., Smith, T. W., Martínez, A. C., Arpa, J., Martínez, N., Iváñez, V., et al. (1995) · Muscle & Nerve · doi:10.1002/mus.880180516 · Cited by 49
Faager, G., Söderlund, K., Sköld, C. M., Rundgren, S., Tollbäck, A., & Jakobsson, P. (2006) · International Journal of COPD · doi:10.2147/copd.2006.1.4.445 · Cited by 45
Coplan, J. D., Mathew, S. J., Mao, X., Smith, E. L. P., Hof, P. R., Coplan, P. M., Rosenblum, L. A., Gorman, J. M., & Shungu, D. C. (2006) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2005.12.011 · Cited by 45
Creatine for treating muscle disorders
Kley, R. A., Vorgerd, M., & Tarnopolsky, M. A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004760.pub2 · Cited by 45
Funanage, V. L., Carango, P., Shapiro, I. M., Tokuoka, T., & Tuan, R. S. (1992) · Bone and Mineral · doi:10.1016/0169-6009(92)90742-v · Cited by 39
No effect of creatine on respiratory distress in amyotrophic lateral sclerosis
Drory, V. E., & Gross, D. (2002) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608202317576534 · Cited by 38
Green, H. J., Burnett, M. E., D'Arsigny, C. L., O'Donnell, D. E., Ouyang, J., & Webb, K. A. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90458.2008 · Cited by 38
Open Study of Creatine Monohydrate in Treatment-Resistant Posttraumatic Stress Disorder
Amital, D., Vishne, T., Roitman, S., Kotler, M., & Levine, J. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0521c · Cited by 37
Possible role of creatine concentrations in the brain in regulating appetite and weight
Galbraith, R. A., Furukawa, M., & Li, M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.05.032 · Cited by 37
Renal dysfunction accompanying oral creatine supplements
Poortmans, Jr., & Francaux, M. (1998) · The Lancet · doi:10.1016/s0140-6736(05)77836-3 · Cited by 37
Self-citationDeyn, P. P. D., & Wirshing, W. C. (2001) · PubMed · Cited by 36
Effects of creatine supplementation in the Thoroughbred horse
SEWELL, D. A., & HARRIS, R. C. (1995) · Equine Veterinary Journal · doi:10.1111/j.2042-3306.1995.tb04928.x · Cited by 36
Creatine monohydrate in DM2/PROMM: a double-blind placebo-controlled clinical study
Schneider–Gold, C., Beck, M., Wessig, C., George, A., Kele, H., Reiners, K., & Toyka, K. V. (2003) · Neurology · doi:10.1212/01.wnl.0000044405.29988.e1 · Cited by 35
Bourgeois, J. M., Nagel, K., Pearce, E., Wright, M., Barr, R. D., & Tarnopolsky, M. A. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21571 · Cited by 35
Observed Effects of Creatine Monohydrate in a Patient With Depression and Fibromyalgia
Amital, D., Vishne, T. H., Rubinow, A., & LEVINE, J. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.10.1840b · Cited by 32
Op't Eijnde, B., Jijakli, H., Hespel, P., & Malaisse, W. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.6.1077 · Cited by 29
RENAL INSUFFICIENCY AFTER CREATINE SUPPLEMENTATION IN A COLLEGE FOOTBALL ATHLETE
Kuehl, K., Goldberg, L., & Elliot, D. (1998) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199805001-01336 · Cited by 28
Smith, C. A., Chetlin, R. D., Gutmann, L., Yeater, R. A., & Alway, S. E. (2006) · Muscle & Nerve · doi:10.1002/mus.20621 · Cited by 26
Sömjen, D., Kaye, A. M., Rodan, G. A., & Binderman, I. (1985) · Calcified Tissue International · doi:10.1007/bf02554922 · Cited by 20 · cited 1×
“, insulin growth factor 1 and parathyroid hormone) also result in increased PCK activity (Somjen and Kaye 1994; Somjen et al. 1985).”
BackgroundEssentials of Creatine in Sports and Health
(2008) · Humana Press eBooks · doi:10.1007/978-1-59745-573-2 · Cited by 16
Sömjen, D., & Kaye, A. M. (1994) · Journal of Endocrinology · doi:10.1677/joe.0.1430251 · Cited by 16 · cited 1×
“, insulin growth factor 1 and parathyroid hormone) also result in increased PCK activity (Somjen and Kaye 1994; Somjen et al. 1985).”
BackgroundÖzkan, Ö., Duman, Ö., Haspolat, Ş., Özgentaş, H. E., Dikici, M. B., Gürer, İ. E., Güngör, H. A., & Gökhan, G. A. (2005) · Journal of Reconstructive Microsurgery · doi:10.1055/s-2005-922438 · Cited by 14 · cited 1×
“Interestingly, a body of literature indicates that energetic disturbances induced by ischemia, cerebral vascular stroke, spinal cord injury, and cerebral trauma might be attenuated by Cr treatment (Adcock et al. 2002; Lensman et al. 2006; Ozkan et al. 2005; Scheff and Dhillon 2004).”
BackgroundDevelopmental Expression of Creatine Kinase Isoenzymes in Chicken Growth Cartilage
Hobson, G. M., Funanage, V. L., Elsemore, J., Yagami, M., Rajpurohit, R., Perriard, J., Hickok, N. J., Shapiro, I. M., & Tuan, R. S. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.5.747 · Cited by 13 · cited 1×
“Similarly, it has been noted that chondrocyte hypertrophy is related to PCK overexpression (Hobson et al. 1999).”
BackgroundCreatine Consumption in Health
Poortmans, J. R., & Francaux, M. (2008) · Essentials of Creatine in Sports and Health · doi:10.1007/978-1-59745-573-2_5 · Cited by 6 · cited 2×
“However, our groups (Gualano et al. 2008c; Poortmans 1998; Poortmans and Francaux 2008 Poortmans et al. 1997; Poortmans and Francaux 1999, 2000; Poortmans et al. 2005; Poortmans and Francaux 2008) and others (Kreider et al.”
BackgroundSelf-citationGualano, B., Ugrinowitsch, C., Artioli, G. G., Benatti, F. B., Scagliusi, F. B., Harris, R. C., & Lancha, A. H. (2008) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-5-16 · Cited by 6
Self-citationTarnopolsky (1999) · doi:10.1002/(sici)1097-4598(199909)22:9<1228::aid-mus9>3.0.co;2-6
Cited by
Antonio, J., Candow, D. G., Forbes, S. C., Gualano, B., Jagim, A. R., Kreider, R. B., Rawson, E. S., Smith-Ryan, A. E., VanDusseldorp, T. A., Willoughby, D. S., et al. (2021) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-021-00412-w · Cited by 345
Self-citationCreatine supplementation with specific view to exercise/sports performance: An update
Cooper, R., Naclerio, F., Allgrove, J., & Jimenez, A. (2012) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-9-33 · Cited by 306
Creatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
“Thus, there is evidence to suggest that creatine supplementation enhances glucose uptake and insulin sensitivity and, therefore, can help individuals manage glucose and HbA1c levels, particularly when initiating an exercise program [10,11,186].”
BackgroundPost, A., Tsikas, D., & Bakker, S. J. L. (2019) · Nutrients · doi:10.3390/nu11051044 · Cited by 223
Sestili, P., Martinelli, C., Colombo, E., Barbieri, E., Potenza, L., Sartini, S., & Fimognari, C. (2011) · Amino Acids · doi:10.1007/s00726-011-0875-5 · Cited by 200
Metadata
- Authors
- Gualano, B., Artioli, G. G., Poortmans, J. R., & Lancha Junior, A. H.
- Affiliations
- Universidade de São Paulo (BR)
- Université Libre de Bruxelles (BE)
- Corresponding author
- Gualano, Bruno
- Venue
- Amino Acids
- Published
- 2009-03-01
- Volume
- 38
- Issue
- 1
- Pages
- 31-44
- ISSN
- 0939-4451 (ISSN-L)
- 1438-2199
- OpenAlex
- W2090042942
- Cited by
- 156
- References
- 139
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 5 · 2023: 8 · 2022: 11 · 2021: 14 · 2020: 4 · 2019: 11 · 2018: 6 · 2017: 9 · 2016: 10 · 2015: 7 · 2014: 8 · 2013: 10 · 2012: 8
- FWCI
- 1.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Amino Acids (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Health Sciences › Medicine › Physiology (medical) › Biochemical effects in animals
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- creatine supplementation, creatine kinase, satellite cell activation, muscle atrophy, Duchenne muscular dystrophy, myositis, Parkinson's disease, Huntington's disease, Alzheimer's disease, osteoporosis, type 2 diabetes, muscle weakness, metabolic disorders
- MeSH terms
- Central Nervous System Diseases, Creatine, Humans, Metabolic Diseases, Muscular Diseases, Randomized Controlled Trials as Topic, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.